Senior MRC scientist joins UK dementia charity

16 May 2024
jo-latimer-large

Jo Latimer (pictured above), head of neurosciences and mental health at the UK’s Medical Research Council (MRC), has been appointed chief scientific officer at a charity performing research in the dementia field.

Beginning mid-August, Dr Latimer will take up the role with the UK Dementia Research Institute (UK DRI), a multimillion-pound investment which is principally funded by MRC.

During 17 years with MRC, Dr Latimer has held responsibilities for scientific areas in neurodegeneration, neurophysiology and translational research as well as leading on industry liaison.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical